Skip to main content

Table 1 Chromosomal aberrations detected primarily by the MLPA testing panels

From: Investigation of selected genomic deletions and duplications in a cohort of 338 patients presenting with syndromic obesity by multiplex ligation-dependent probe amplification using synthetic probes

Case

Cytoband

CNV type

Aberrant MLPA probe(s)

CMA/ MLPA

Genomic coordinates

Size (Mb)

Inheritance

Phenotype

P1

1q21.1

Gain

PRKAB2, ACP6

180 K oligoarray

chr1:146.07-147.83 Mb

1.8

n.d.

6.8 yr old male (BMI >95th), speech delay (>2 yr), macrocephaly (>98th), accelerated growth (90-95th), genital hypoplasia

P2

2q37.1q37.2

Gain

--

500 K SNP array

chr2:235.09-236.8 Mb

1.7

--

11 yr old male (BMI >95th), DD (walked: 3.6 yr, spoke: 3 yr); ID, hypotonia, motor and speech impairment, hyperphagia, seizures, macrocephaly (98th), facial dysmorphisms, inverted nipples, unilateral cryptorchidism

2q37.2q37.3

Loss

HDAC4, GPR35

chr2:236.94-243.01 Mb

6.1

de novo

P3

2q37.2q37.3

Loss

HDAC4, GPR35

60 K oligoarray

chr2:236.85-243.0 Mb

6.2

n.d.

21 yr old male; DD, hypotonia, hyperphagia, obesity, absent speech, mild dysmorphisms, supernumerary teeth, unilateral cryptorchidism, micropenis

P4

2q37.2q37.3

Loss

HDAC4, GPR35

60 K oligoarray

chr2:237.22-243.0 Mb

5.8

de novo

8 yr old female (BMI >95th), DD (walked: 17mo, spoke: >2 yr), learning disability, dolichocephaly, facial dysmorphisms, mamilar hypertelorism, inverted nipples, brachydactyly, 2–3 toe syndactyly, hirsutism, joint hypermobility

P5

2q37.3

Loss

GPR35

180 K oligoarray

chr2:240.88-243.03 Mb

2.2

n.d.

5 yr old female (BMI >95th), DD (walked: 2 yr, spoke: 3 yr), ID, behavior problems, prominent ear, thin elongated eyebrow, strabismus

17q25.3

Gain

--

chr17:78.77-81.06 Mb

2.3

P6

9q34.3

Loss

EHMT1

60 K oligoarray

chr9:140.67-141.02 Mb

0.4

de novo

9.5 yr old female (BMI >95th), DD (walked: 18mo, spoke: 6 yr), hypotonia, hyperphagia, behavior problems, tall stature (>97th)

P7

16p11.2

Loss

SH2B1

180 K and 60 K oligoarray

chr16:28.82-29.04 Mb

0.2

de novo

7 yr old female (BMI >95th), GDD, hypotonia, ADHD, hyperphagia, speech impairment, deep-set eyes, straight eyebrows, thick earlobe

P8

16p11.2

Gain

CDIPT, MAPK3

180 K and 60 K oligoarray

chr16:29.65-30.19 Mb

0.5

paternal

8.5 yr old male, GDD, hyperphagia, obesity [sic], speech impairment, behavior problems, scoliosis

P9

17p11.2

Loss

FLCN,1 RAI1

P064 kit

chr17:17.13-19.29 Mb

2.2

de novo

11 yr old male (BMI >95th), DD, ID, hyperphagia, behavior and sleep problems, macrocephaly (>98th), typical facial dysmorphisms, brachydactyly, 2–3 toe syndactyly, micropenis

P10

17p11.2

Loss

FLCN,1 RAI1

P064 kit

chr17:16.85-19.29 Mb

2.4

de novo

10 yr old male (BMI >95th), DD, ID, hypotonia, hyperphagia, behavior and sleep problems, speech and hearing impairment, facial dysmorphism

P11

17p11.2

Loss

FLCN,1 RAI1

P064 kit

chr17:16.85-19.29 Mb

2.4

de novo

7 yr old female (BMI >95th), DD (walked: 2 yr, spoke: 5 yr), ID, behavior problems, myopia, strabismus, astigmatisms, hypoplasia genital, 2–3 toe syndactyly

P12

17p11.2

Loss

FLCN,1 RAI1

P064 kit

chr17:16.85-19.29 Mb

2.4

n.d.

6.8 yr old male (BMI >95th), DD (walked: 5 yr, spoke: >4 yr), hypotonia, hyperphagia, compulsive behavior, typical facial dysmorphisms

P13

22q11.21

Loss

CRKL

P023 kit

chr22:19.32-21.35 Mb

2.0

de novo

3 yr old male (weight >97th), GDD, absent speech, hypotonia, mild facial dysmorphism

P14

22q11.21

Loss

CRKL

P023 kit

chr22:19.32-21.35 Mb

2.0

de novo

9 yr old male (BMI >95th), ID, hypotonia, speech delay (>3 yr), behavior problems, ADHD, hyperphagia, accelerated growth (90-95th), hypogonadism

P15

22q11.21

Loss

CRKL

P023 kit

chr22:19.32-21.35 Mb

2.0

paternal

13mo old male (BMI 76th), DD, hypotonia, growth delay (3rd-5th), relative overweight (weight to height ratio >75th percentile), dolichocephaly, facial dysmorphisms

P16

22q11.21

Gain

CRKL

P023 kit

chr22:19.32-21.35 Mb

2.0

paternal

8.6 yr old male (weight >97th), DD (walked: >2 yr), mild ID, hypotonia, facial dysmorphisms, widened mediastinum, brachydactyly, micropenis

P17

22q11.22q11.23

Loss

RAB36

180 K oligoarray

chr22:23.01-23.65 Mb

0.6

maternal

2.8 yr old female (BMI 85th), hypotonia, non-ambulatory and non-verbal, epilepsy (onset at 3mo), brachycephaly, deep-set eyes, visual impairment, joint laxity

P18

22q11.22q11.23

Loss

RAB36

500 K SNP array

chr22:23.06-23.7 Mb

0.6

n.d.2

15 yr old male (BMI >95th), GDD, ID, hypotonia, absent speech, behavioral and sleep problems, facial dysmorphisms, strabismus, hyperprolactinemia, micropenis

  1. Breakpoints based on the coordinates of the first and last altered array probes. The alterations of patients 9–12 and 13–16 were fine-mapped by additional MLPA probes in the commercial kits P064-B2 and P023-B, respectively. Probes in the MLPA kit P064-B2 covering the 17p11.2 region are TNFRSF13B, LRRC48, LLGL1, PRPSAP2 and MFAP4. Probes in the MLPA kit P023-B covering the 22q11 region are IL17R, BID, HIRA, CLDN5, KIAA1652, KLHL22, PCQAP, SNAP29, LZTR1 and MIF.
  2. 1The FLCN probe is included in the MLPA P200 and P300 reference kits. It is located within the SMS region on chromosome 17p11.2, and was found deleted in all patients with deletions in RAI1. 2Adopted child. Not determined (n.d.); years (yr); months (mo). ID, intellectual disability; DD, developmental delay; GDD, global DD; ADHD, attention-deficit hyperactivity disorder.